招商国证生物医药指数(LOF)C(012417)资产负债表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
591,892.83 |
56.09 |
1,437,013.63 |
1,657,130.72 |
| 存出保证金 |
689,375.45 |
363,519.84 |
519,460.87 |
328,678.28 |
| 交易性金融资产 |
7,753,474,516.63 |
8,718,812,255.29 |
9,483,925,432.28 |
9,171,151,212.95 |
| 其中：股票投资 |
7,747,407,586.22 |
8,701,038,424.17 |
9,274,061,333.60 |
8,842,370,317.98 |
| 债券投资 |
6,066,930.41 |
17,773,831.12 |
209,864,098.68 |
328,780,894.97 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
118,865.20 |
31,331.66 |
- |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
19,358,993.46 |
8,071,829.76 |
18,611,631.92 |
16,670,530.00 |
| 其他资产 |
- |
- |
- |
19,754.72 |
| 资产总计 |
8,206,828,008.04 |
9,221,366,401.04 |
9,865,255,597.51 |
9,410,842,108.43 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
- |
- |
- |
9,817,157.36 |
| 应付赎回款 |
38,477,060.34 |
34,399,794.69 |
40,975,481.98 |
32,840,271.61 |
| 应付管理人报酬 |
7,076,615.18 |
7,575,096.15 |
8,780,805.37 |
7,991,165.59 |
| 应付托管费 |
1,415,323.04 |
1,515,019.25 |
1,756,161.09 |
1,598,233.11 |
| 应付销售服务费 |
124,040.33 |
137,592.20 |
173,487.11 |
152,998.06 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
412.13 |
4,209.50 |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
216,394.42 |
745,159.57 |
2,327,897.37 |
2,491,311.65 |
| 负债合计 |
47,309,433.31 |
44,372,661.86 |
54,014,245.05 |
54,895,346.88 |
| 所有者权益 |
| 实收基金 |
14,307,307,460.88 |
16,691,273,020.14 |
18,374,975,674.73 |
18,609,163,778.99 |
| 未分配利润 |
-6,147,788,886.15 |
-7,514,279,280.96 |
-8,563,734,322.27 |
-9,253,217,017.44 |
| 所有者权益合计 |
8,159,518,574.73 |
9,176,993,739.18 |
9,811,241,352.46 |
9,355,946,761.55 |
| 负债及所有者权益总计 |
8,206,828,008.04 |
9,221,366,401.04 |
9,865,255,597.51 |
9,410,842,108.43 |
微信公众号
证券之星APP
基本资料
